Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Transcriptome profiling and the pathogenesis of diabetic complications.

Connolly SB, Sadlier D, Kieran NE, Doran P, Brady HR.

J Am Soc Nephrol. 2003 Aug;14(8 Suppl 3):S279-83. Review.

2.
3.

Role for poly(ADP-ribose) polymerase activation in diabetic nephropathy, neuropathy and retinopathy.

Obrosova IG, Julius UA.

Curr Vasc Pharmacol. 2005 Jul;3(3):267-83. Review.

PMID:
16026323
4.

Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli.

Wahab NA, Schaefer L, Weston BS, Yiannikouris O, Wright A, Babelova A, Schaefer R, Mason RM.

Diabetologia. 2005 Dec;48(12):2650-60. Epub 2005 Nov 4.

PMID:
16270194
5.

Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy.

Yamagishi S, Imaizumi T.

Curr Pharm Des. 2005;11(18):2279-99. Review.

PMID:
16022668
6.

Salutary effect of pigment epithelium-derived factor in diabetic nephropathy: evidence for antifibrogenic activities.

Wang JJ, Zhang SX, Mott R, Knapp RR, Cao W, Lau K, Ma JX.

Diabetes. 2006 Jun;55(6):1678-85.

7.
8.
9.

Regulation and consequences of differential gene expression in diabetic kidney disease.

Murphy M, Crean J, Brazil DP, Sadlier D, Martin F, Godson C.

Biochem Soc Trans. 2008 Oct;36(Pt 5):941-5. doi: 10.1042/BST0360941.

PMID:
18793165
10.

A novel potential therapy for diabetic nephropathy and vascular complications: protein kinase C beta inhibition.

Tuttle KR, Anderson PW.

Am J Kidney Dis. 2003 Sep;42(3):456-65. Review.

PMID:
12955673
11.

The importance of diabetic nephropathy in current nephrological practice.

Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C.

Nephrol Dial Transplant. 2003 Sep;18(9):1716-25. Review.

12.

Advanced glycation end products cause increased CCN family and extracellular matrix gene expression in the diabetic rodent retina.

Hughes JM, Kuiper EJ, Klaassen I, Canning P, Stitt AW, Van Bezu J, Schalkwijk CG, Van Noorden CJ, Schlingemann RO.

Diabetologia. 2007 May;50(5):1089-98. Epub 2007 Feb 28.

13.

Agents in development for the treatment of diabetic nephropathy.

Goh SY, Jasik M, Cooper ME.

Expert Opin Emerg Drugs. 2008 Sep;13(3):447-63. doi: 10.1517/14728214.13.3.447 . Review.

PMID:
18764722
14.

Biochemical pathways for microvascular complications of diabetes mellitus.

Setter SM, Campbell RK, Cahoon CJ.

Ann Pharmacother. 2003 Dec;37(12):1858-66. Review.

PMID:
14632543
15.

Differences in gene expression profiles of diabetic and nondiabetic patients undergoing cardiopulmonary bypass and cardioplegic arrest.

Voisine P, Ruel M, Khan TA, Bianchi C, Xu SH, Kohane I, Libermann TA, Otu H, Saltiel AR, Sellke FW.

Circulation. 2004 Sep 14;110(11 Suppl 1):II280-6.

16.
17.

HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis: role of RhoA/ROCK and MAPK pathways.

Rupérez M, Rodrigues-Díez R, Blanco-Colio LM, Sánchez-López E, Rodríguez-Vita J, Esteban V, Carvajal G, Plaza JJ, Egido J, Ruiz-Ortega M.

Hypertension. 2007 Aug;50(2):377-83. Epub 2007 Jun 25.

18.

Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice.

Lewis P, Stefanovic N, Pete J, Calkin AC, Giunti S, Thallas-Bonke V, Jandeleit-Dahm KA, Allen TJ, Kola I, Cooper ME, de Haan JB.

Circulation. 2007 Apr 24;115(16):2178-87. Epub 2007 Apr 9.

19.

The Rho-kinase inhibitor, fasudil, attenuates diabetic nephropathy in streptozotocin-induced diabetic rats.

Gojo A, Utsunomiya K, Taniguchi K, Yokota T, Ishizawa S, Kanazawa Y, Kurata H, Tajima N.

Eur J Pharmacol. 2007 Jul 30;568(1-3):242-7. Epub 2007 Apr 20.

PMID:
17511984
20.

[Investigation of a novel mechanism of diabetic complications: impacts of mitochondrial reactive oxygen species].

Nishikawa T, Araki E.

Rinsho Byori. 2008 Aug;56(8):712-9. Review. Japanese.

PMID:
18800628
Items per page

Supplemental Content

Write to the Help Desk